INVASIVE PULMONARY ASPERGILLOSIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. P. BULPA, A. DIVE AND Y. SIBILLE. EUR RESPIR J 2007; 30: 782 800.


Source: Eur Respir J 2007; 30: 1236
Journal Issue: December

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
INVASIVE PULMONARY ASPERGILLOSIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. P. BULPA, A. DIVE AND Y. SIBILLE. EUR RESPIR J 2007; 30: 782 800.. Eur Respir J 2007; 30: 1236

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. B.R. CELLI AND P.J. BARNES. EUR RESPIR J 2007; 29: 1224 1238.
Source: Eur Respir J 2007; 30: 401
Year: 2007


“ASSESSING THE TREATMENT EFFECT FROM MULTIPLE TRIALS IN IDIOPATHIC PULMONARY FIBROSIS.” L. RICHELDI. EUR RESPIR REV 2012; 21: 147–151.
Source: Eur Respir Rev 2012 21:263
Year: 2012


"PROGRESSION OF SNORING AND OBSTRUCTIVE SLEEP APNOEA: THE ROLE OF INCREASING WEIGHT AND TIME". G. BERGER, R. BERGER AND A. OKSENBERG. EUR RESPIR J 2009; 33: 338-345.
Source: Eur Respir J 2009; 33: 947
Year: 2009


"FREQUENCY AND CLINICAL CHARACTERISTICS OF RAPID-ONSET FATAL AND NEAR-FATAL ASTHMA". V. PLAZA, J. SERRANO, C. PICADO, J. SANCHIS, ON BEHALF OF THE HIGH RISK ASTHMA RESEARCH GROUP. EUR RESPIR J 2002; 19: 846-852.
Source: Eur Respir J 2009; 33: 1240
Year: 2009


"BECLOMETHASONE/FORMOTEROL VERSUS BUDESONIDE/FORMOTEROL COMBINATION THERAPY IN ASTHMA". A. PAPI, P.L. PAGGIARO, G. NICOLINI, A.M. VIGNOLA AND L.M. FABBRI ON BEHALF OF THE INHALED COMBINATION ASTHMA TREATMENT VERSUS SYMBICORT (ICAT SY) STUDY GROUP. EUR RESPIR J 2007; 29: 682-689.
Source: Eur Respir J 2008; 32: 822
Year: 2008


RELATIONSHIP BETWEEN RESPIRATORY SYMPTOMS AND MEDICAL TREATMENT IN EXACERBATIONS OF COPD. EUR RESPIR J 2005; 26: 406-413.
Source: Eur Respir J 2006; 27: 440
Year: 2006


ERS/ESTS CLINICAL GUIDELINES ON FITNESS FOR RADICAL THERAPY IN LUNG CANCER PATIENTS (SURGERY AND CHEMO-RADIOTHERAPY). A. BRUNELLI, A. CHARLOUX, C.T. BOLLIGER, G. ROCCO, J-P. SCULIER, G. VARELA, M. LICKER, M.K. FERGUSON, C. FAIVRE-FINN, R.M. HUBER, E.M. CLINI, T. WIN, D. DE RUYSSCHER AND L. GOLDMAN ON BEHALF OF THE EUROPEAN RESPIRATORY SOCIETY AND EUROPEAN SOCIETY OF THORACIC SURGEONS JOINT TASK FORCE ON FITNESS FOR RADICAL THERAPY. EUR RESPIR J 2009; 34: 17-41.
Source: Eur Respir J 2009; 34: 782
Year: 2009


ANTIBIOTICS FOR CHRONIC BRONCHITIS: A META-ANALYSIS THAT SPEAKS ONLY FOUR LANGUAGES. M. MIRAVITLLES, B. CELLI AND A. ANZUETO. EUR RESPIR J 2007; 30: 815.
Source: Eur Respir J 2007; 30: 1236
Year: 2007


BECLOMETHASONE/FORMOTEROL VERSUS BUDESONIDE/FORMOTEROL COMBINATION THERAPY IN ASTHMA. A. PAPI, P.L. PAGGIARO, G. NICOLINI, A.M. VIGNOLA AND L.M. FABBRI ON BEHALF OF THE INHALED COMBINATION ASTHMA TREATMENT VERSUS SYMBICORT (ICAT SY) STUDY GROUP. EUR
Source: Eur Respir J 2007; 29: 1286
Year: 2007


IMPACT OF CHRONIC ANEMIA ON THE EVOLUTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION (COPDE)
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


PROGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ACCORDING TO STRENGTH IN UPPER LIMBS
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019



EXCLUSION OF ACTIVE MYCOBACTERIUM TUBERCULOSIS COMPLEX INFECTION WITH THE T-SPOTTM.TB ASSAY. R.M.L. VAN LEEUWEN, A.W.J. BOSSINK AND S.F.T. THIJSEN. EUR RESPIR J 2007; 29: 605-607.
Source: Eur Respir J 2007; 29: 1286
Year: 2007


"REDUCED MITOCHONDRIAL DENSITY IN THE VASTUS LATERALIS MUSCLE OF PATIENTS WITH COPD". H.R. GOSKER, M.K.C. HESSELINK, H. DUIMEL, K.A. WARD AND A.M.W.J. SCHOLS. EUR RESPIR J 2007; 30: 73 79.
Source: Eur Respir J 2007; 30: 817
Year: 2007


BUDESONIDE/FORMOTEROL MAINTENANCE AND RELIEVER THERAPY: AN EFFECTIVE ASTHMA TREATMENT OPTION? EUR RESPIR J 2005; 26: 819-828.
Source: Eur Respir J 2005; 26: 1191
Year: 2005


PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ADMITTED FOR PNEUMONIA ACQUIRED IN THE COMMUNITY.
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020


"AIRWAY DENDRITIC CELL PHENOTYPES IN INFLAMMATORY DISEASES OF THE HUMAN LUNG". M. LOMMATZSCH, K. BRATKE, A. BIER, P. JULIUS, M. KUEPPER, W. LUTTMANN AND J.C. VIRCHOW. SO - Eur Respir J 2007; 30: 878 886.
Source: Eur Respir J 2008; 31: 226
Year: 2008


ANGIOTENSIN II BLOCKERS IN OBSTRUCTIVE PULMONARY DISEASE: A RANDOMISED CONTROLLED TRIAL.
Source: Eur Respir J 2006; 28: 1292
Year: 2006


EVALUATION OF SMALL AIRWAY DISEASE (SAD) IN ASTHMA. CONCORDANCES AND DISCREPANCES BETWEEN DIFFERENT TECHNIQUES.
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019

"LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN IDIOPATHIC PULMONARY FIBROSIS: A TISSUE DOPPLER ECG STUDY". C.E. PAPADOPOULOS, G. PITSIOU, T.D. KARAMITSOS, H.I. KARVOUNIS, T. KONTAKIOTIS, G. GIANNAKOULAS, G.K. EFTHIMIADIS, P. ARGYROPOULOU, G.E. PARHARIDIS AND D. BOUROS. EUR RESPIR J 2008; 31: 701-706.
Source: Eur Respir J 2008; 32: 534
Year: 2008


DIFFERENCES IN HOSPITAL COURSE IN COMMUNITY ACQUIRED PNEUMONIA (CAP) ACCORDING TO ANTIBIOTIC TREATMENT
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019